Needham & Company LLC reissued their buy rating on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a report published on Monday morning, Benzinga reports. Needham & Company LLC currently has a $26.00 target price on the stock. Phathom Pharmaceuticals Price Performance Shares of NASDAQ:PHAT opened at $10.62 on Monday. Phathom Pharmaceuticals has a […]